[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ardelyx Inc (ARDX)

Ardelyx Inc (ARDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 996,752
  • Shares Outstanding, K 249,188
  • Annual Sales, $ 407,320 K
  • Annual Income, $ -61,600 K
  • EBIT $ -35 M
  • EBITDA $ -32 M
  • 60-Month Beta 0.70
  • Price/Sales 2.45
  • Price/Cash Flow N/A
  • Price/Book 6.65

Options Overview Details

View History
  • Implied Volatility 58.96% (-7.83%)
  • Historical Volatility 60.44%
  • IV Percentile 15%
  • IV Rank 12.46%
  • IV High 151.31% on 02/06/26
  • IV Low 45.81% on 08/21/25
  • Expected Move (DTE 10) 0.30 (7.40%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 257
  • Volume Avg (30-Day) 2,774
  • Put/Call OI Ratio 1.06
  • Today's Open Interest 93,883
  • Open Int (30-Day) 57,404
  • Expected Range 3.72 to 4.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.02
  • Number of Estimates 5
  • High Estimate $0.04
  • Low Estimate $-0.06
  • Prior Year $0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.90 +3.72%
on 08/10/26
5.32 -23.89%
on 07/15/26
-1.24 (-23.39%)
since 07/10/26
3-Month
3.90 +3.72%
on 08/10/26
6.68 -39.49%
on 05/12/26
-2.57 (-38.80%)
since 05/11/26
52-Week
3.90 +3.72%
on 08/10/26
8.40 -51.85%
on 01/23/26
-1.36 (-25.09%)
since 08/11/25

Most Recent Stories

More News
Ardelyx: Q2 Earnings Snapshot

Ardelyx: Q2 Earnings Snapshot

ARDX : 4.01 (+0.25%)
Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update

Q2 2026 total product revenue of $118.1 million, reflecting 31% growth year-over-year IBSRELA Q2 2026 revenue growth of 33% year-over-year to $86.2 million XPHOZAH Q2 2026 revenue...

ARDX : 4.01 (+0.25%)
Can Ardelyx Prove Its Commercial Execution Matches the Pipeline Promises?

Barchart Research What to Expect from ARDX Earnings ARDX Generated August 5, 2026 Current Price $4.91 EPS Estimate $$-0.05 Consensus Rating Strong Buy Average Move 14.32% Can Ardelyx Prove Its Commercial...

ARDX : 4.01 (+0.25%)
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026

WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX) (“Ardelyx” or the “Company”), a commercial-stage biopharmaceutical company focused on the development and commercialization...

ARDX : 4.01 (+0.25%)
Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach

Ardelyx (NASDAQ:ARDX) executives said at the Jefferies Global Healthcare Conference that the company is focused on expanding demand for its commercial products, IBSRELA and XPHOZAH, while continuing to...

ARDX : 4.01 (+0.25%)
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026

WALTHAM, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the development and commercialization...

ARDX : 4.01 (+0.25%)
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings

WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that...

ARDX : 4.01 (+0.25%)
Ardelyx: Q1 Earnings Snapshot

Ardelyx: Q1 Earnings Snapshot

ARDX : 4.01 (+0.25%)
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update

Q1 2026 total product revenue of $93.4 million, reflecting 38% growth year-over-year IBSRELA Q1 2026 revenue growth of 58% year-over-year to $70.1 million; Reiterating guidance of $410-$430 million...

ARDX : 4.01 (+0.25%)
Ardelyx Earnings May Confirm Whether IBSRELA's Growth Trajectory Is Real or Rhetorical

Barchart Research What to Expect from ARDX Earnings ARDX Generated April 29, 2026 Current Price $6.01 EPS Estimate $$-0.13 Consensus Rating Strong Buy Average Move 18.26% Ardelyx Earnings May Confirm Whether...

ARDX : 4.01 (+0.25%)

Business Summary

Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase...

See More

Key Turning Points

3rd Resistance Point 4.33
2nd Resistance Point 4.23
1st Resistance Point 4.11
Last Price 4.01
1st Support Level 3.89
2nd Support Level 3.79
3rd Support Level 3.67

See More

52-Week High 8.40
Fibonacci 61.8% 6.68
Fibonacci 50% 6.15
Fibonacci 38.2% 5.62
Last Price 4.01
52-Week Low 3.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.